New $2.8-million gene therapy becomes most expensive medicine in history
“The US Food and Drug Administration (FDA) has approved the first [MORE]
Sickle Cell Anemia
“In a late-breaking abstract presented at the European Hematology Association (EHA) Congress, a group of researchers that includes [MORE]
CRISPR therapy for rare blood diseases
“Back in 2019 the first CRISPR human clinical trials kicked off in the United States. [MORE]
Base Editing
CRISPR-Cas9 gene editing is the new tool in the box of molecular surgeons, but this method deletes multiple bases [MORE]